Blood tests may reveal earliest signs of Alzheimer's

NCT ID NCT06880406

Recruiting now Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at early changes in mitochondria (the energy centers of cells) and metabolic markers in blood cells of people with Alzheimer's or related dementias. Researchers will compare these measures between those with and without Alzheimer's to find clues about how the disease starts. The goal is to better understand the disease process and identify potential early warning signs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could identify early biological markers for Alzheimer's, potentially leading to earlier diagnosis or new treatment targets.
What could go wrong: This is an observational study, not a treatment trial. It may not directly lead to therapies, and findings may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER DISEASE

Contacts and locations

Locations

CHU de Nice
RECRUITING

Nice, PACA, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.